Exact Sciences Corporation EXAS
$ 53.87
2.22%
Quarterly report 2024-Q3
added 11-05-2024
Exact Sciences Corporation Balance Sheet 2011-2024 | EXAS
Annual Balance Sheet Exact Sciences Corporation
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-568 M | -207 M | -283 M | -137 M | 651 M | 528 M | -73 M | -44.1 M | -36.1 M | 167 M | 109 M | 82.4 M | 22.8 M |
Long Term Debt |
7.5 M | 7.4 M | 12.5 M | 1.34 B | 828 M | 689 M | 4.27 M | 4.63 M | 4.85 M | 1 M | 1 M | 1 M | 1 M |
Long Term Debt Current |
29.4 M | 28.4 M | 19.7 M | 11.5 M | 7.89 M | 8 K | 182 K | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 981 M | 706 M | 10 M | 11.1 M | 10.7 M | 5.12 M | 3.56 M | 2.07 M | 5.48 M |
Total Current Liabilities |
515 M | 413 M | 517 M | 576 M | 236 M | 137 M | 68.1 M | 30.7 M | 26.7 M | 17.5 M | 7.75 M | 11.5 M | 7.98 M |
Total Liabilities |
3.33 B | 3.18 B | 3.3 B | 2.1 B | 1.22 B | 843 M | 78.1 M | 41.7 M | 37.4 M | 22.6 M | 11.3 M | 13.5 M | 13.5 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | 4.14 M |
Retained Earnings |
-3.47 B | -3.27 B | -2.64 B | -1.97 B | -1.12 B | -1.04 B | -861 M | -746 M | -579 M | -421 M | -321 M | -274 M | -222 M |
Total Assets |
6.47 B | 6.23 B | 6.68 B | 4.93 B | 3.51 B | 1.52 B | 599 M | 377 M | 364 M | 312 M | 147 M | 112 M | 97 M |
Cash and Cash Equivalents |
605 M | 242 M | 315 M | 1.49 B | 177 M | 160 M | 77.5 M | 48.9 M | 41.1 M | 58.1 M | 12.9 M | 13.3 M | 35.8 M |
Book Value |
3.15 B | 3.04 B | 3.39 B | 2.82 B | 2.29 B | 681 M | 520 M | 335 M | 327 M | 289 M | 135 M | 98.6 M | 83.5 M |
Total Shareholders Equity |
3.15 B | 3.04 B | 3.39 B | 2.24 B | 2.29 B | 681 M | 520 M | 335 M | 327 M | 289 M | 135 M | 98.6 M | 83.5 M |
All numbers in USD currency
Quarterly Balance Sheet Exact Sciences Corporation
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
14.8 M | 15 M | 13.1 M | 7.5 M | 8.4 M | 7.7 M | 6.8 M | 7.4 M | 8 M | - | 11.6 M | 12.5 M | 13.2 M | 13.1 M | 13.2 M | 23.8 M | 14 M | 14 M | 14 M | 24 M | 200 K | 804 M | 24.8 M | 24.5 M | 17.1 M | 878 K | 24.5 M | 4.27 M | 4.27 M | 4.27 M | 4.27 M | 4.63 M | 4.63 M | 4.63 M | 4.63 M | 4.79 M | 4.79 M | 4.79 M | 4.79 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.54 B | 3.48 B | 3.24 B | 3.33 B | 3.3 B | 3.3 B | 3.25 B | 3.18 B | 3.2 B | - | 3.23 B | 3.3 B | 3.2 B | 3.17 B | 3.09 B | 2.69 B | 2.69 B | 2.69 B | 2.69 B | 1.22 B | 1.22 B | 1.22 B | 1.22 B | 843 M | 843 M | 843 M | 843 M | 78.1 M | 78.1 M | 78.1 M | 78.1 M | 41.7 M | 41.7 M | 41.7 M | 41.7 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 11.3 M | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | 2.3 M | - | 1.3 M | 1 M | 18.7 M | 28.7 M | 39.8 M | 25 M | 25 M | 25 M | 25 M | 600 K | 600 K | 600 K | 400 K | 500 K | 500 K | 500 K | 500 K | 200 K | 200 K | 200 K | 200 K | - | - | - | - | - | - | - | - | - | - | - | - | 294 K | 294 K | 294 K | 294 K | 4.14 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M |
Retained Earnings |
-3.63 B | -3.6 B | -3.58 B | -3.47 B | -3.42 B | -3.42 B | -3.34 B | -3.27 B | -3.14 B | - | -2.82 B | -2.64 B | -2.42 B | -2.25 B | -2.08 B | -2.05 B | -2.05 B | -2.05 B | -2.05 B | -1.12 B | -1.12 B | -1.12 B | -1.12 B | -1.04 B | -1.04 B | -1.04 B | -1.04 B | -861 M | -861 M | -861 M | -861 M | -746 M | -746 M | -746 M | -746 M | -579 M | -579 M | -579 M | -579 M | -421 M | -421 M | -421 M | -421 M | -321 M | -321 M | -321 M | -321 M | -274 M | -274 M | -274 M | -274 M | -222 M | -222 M | -222 M | -222 M |
Total Assets |
6.75 B | 6.67 B | 6.38 B | 6.47 B | 6.42 B | 6.36 B | 6.3 B | 6.23 B | 6.31 B | - | 6.49 B | 6.68 B | 6.65 B | 6.72 B | 6.73 B | 4.93 B | 4.93 B | 4.93 B | 4.93 B | 3.51 B | 3.51 B | 3.51 B | 3.51 B | 1.52 B | 1.52 B | 1.52 B | 1.52 B | 599 M | 599 M | 599 M | 599 M | 377 M | 377 M | 377 M | 377 M | 364 M | 364 M | 364 M | 364 M | 313 M | 313 M | 313 M | 313 M | 147 M | 147 M | 147 M | 147 M | 112 M | 112 M | 112 M | 112 M | 97 M | 97 M | 97 M | 97 M |
Cash and Cash Equivalents |
589 M | 530 M | 347 M | 605 M | 595 M | 604 M | 421 M | 242 M | 235 M | 213 M | 190 M | 315 M | 274 M | 364 M | 1.1 B | 1.49 B | 1.49 B | 1.49 B | 1.49 B | 177 M | 177 M | 177 M | 177 M | 160 M | 160 M | 160 M | 160 M | 77.5 M | 77.5 M | 77.5 M | 77.5 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 41.1 M | 41.1 M | 41.1 M | 41.1 M | 58.1 M | 58.1 M | 58.1 M | 58.1 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 13.3 M | 13.3 M | 13.3 M | 35.8 M | 35.8 M | 35.8 M | 35.8 M |
Book Value |
3.21 B | 3.19 B | 3.13 B | 3.15 B | 3.12 B | 3.06 B | 3.06 B | 3.04 B | 3.11 B | - | 3.26 B | 3.39 B | 3.46 B | 3.56 B | 3.65 B | 2.24 B | 2.24 B | 2.24 B | 2.24 B | 2.29 B | 2.29 B | 2.29 B | 2.29 B | 681 M | 681 M | 681 M | 681 M | 520 M | 520 M | 520 M | 520 M | 335 M | 335 M | 335 M | 335 M | 327 M | 327 M | 327 M | 327 M | 289 M | 289 M | 289 M | 289 M | 135 M | 147 M | 147 M | 147 M | 112 M | 112 M | 112 M | 112 M | 97 M | 97 M | 97 M | 97 M |
Total Shareholders Equity |
3.21 B | 3.19 B | 3.13 B | 3.15 B | 3.12 B | 3.06 B | 3.06 B | 3.04 B | 3.11 B | 3.21 B | 3.26 B | 3.39 B | 3.46 B | 3.56 B | 3.65 B | 2.24 B | 2.24 B | 2.24 B | 2.24 B | 1.96 B | 2.29 B | 2.29 B | 2.29 B | 447 M | 681 M | 681 M | 681 M | 520 M | 520 M | 520 M | 520 M | 335 M | 335 M | 335 M | 335 M | 327 M | 327 M | 327 M | 327 M | 289 M | 289 M | 289 M | 289 M | 135 M | 135 M | 135 M | 135 M | 98.6 M | 98.6 M | 98.6 M | 98.6 M | 83.5 M | 83.5 M | 83.5 M | 83.5 M |
All numbers in USD currency